Medical University of Warsaw

In this study, an investigational oral drug named dazucorilant (also called CORT113176) is being studied in people living with ALS.

Archived

PHOENIX

Phase 3

Amylyx Pharmaceuticals Inc is conducting a phase 3 trial to determine the safety and efficacy of their compound 'AMX0035'.

Archived

CardinALS

Phase 2

The CARDINALS clinical research study is evaluating a study drug (Utreloxastat) to see if it can help slow ALS symptoms.

Archived

ADORE

Phase 3

Ferrer is conducting a phase 3 trial to evaluate the safety and potential efficacy of FNP122 for people with ALS.

Archived

COURAGE-ALS

Phase 3

In the COURAGE-ALS study, we are investigating the efficacy and safety of the drug ‘reldesemtiv’ for the treatment of ALS.